Pathological and Clinical Outcomes in a Large Surveillance and Intervention Cohort of Radiographically Cystic Renal Masses. Reply.

No AccessJournal of UrologyReply to Letters to the Editor28 Jun 2023Pathological and Clinical Outcomes in a Large Surveillance and Intervention Cohort of Radiographically Cystic Renal Masses. Reply. Randall A. Lee and Alexander Kutikov Randall A. LeeRandall A. Lee Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author and Alexander KutikovAlexander Kutikov Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003606AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "Pathological and Clinical Outcomes in a Large Surveillance and Intervention Cohort of Radiographically Cystic Renal Masses. Reply.." The Journal of Urology, Publish Ahead of Print, pp. REFERENCES 1. Pathological and clinical outcomes in a large surveillance and intervention cohort of radiographically cystic renal masses. J Urol. 2023; 209(4):686-693. Link, Google Scholar 2. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer. 2012; 118(4):997-1006. Crossref, Medline, Google Scholar 3. . Comprehensive assessment of the impact of cigarette smoking on survival of clear cell kidney cancer. J Urol. 2014; 191(3):597-602. Link, Google Scholar Submitted June 13, 2023; accepted June 15, 2023; published 000. © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Randall A. Lee Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Alexander Kutikov Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Expand All Submitted June 13, 2023; accepted June 15, 2023; published 000. Advertisement PDF downloadLoading ...